Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




AI-Based Automated Quantitative Coronary Angiography Accurately Analyzes Heart Disease

By HospiMedica International staff writers
Posted on 15 Jun 2023

Coronary angiography, a common diagnostic procedure for the treatment of coronary artery disease, requires precise quantitative analysis of stenotic lesions in the coronary artery for optimal clinical decision-making. Stenotic lesions can cause the coronary arteries to narrow, limiting blood flow to the heart. Intravascular ultrasound (IVUS) is a common imaging tool used for evaluating these lesions. With the advent of advanced computer vision and machine learning technology, the automated analysis of coronary angiography has become possible. Now, new research has revealed that artificial intelligence (AI) technology holds significant potential in analyzing coronary angiography.

A study carried out by researchers at Uijeongbu Eulji University Hospital (Uijeongbu, Korea) has demonstrated how AI-based quantitative coronary angiography (AI-QCA) can enhance clinical decision-making. AI-QCA can automatically analyze 2D angiography images and assist physicians in determining the best stent sizes. This technology could enhance patient outcomes and aid clinical decision-making by providing an innovative method to analyze coronary angiography images, offering automated and real-time insights.

The AI-QCA analysis was performed using Medipixel’s (Seoul, Korea) newly-developed MPXA-2000 software which uses an algorithm designed to mimic the QCA process by human experts. The analysis involved 54 significant lesions from 47 patients who underwent IVUS-guided coronary intervention. The researchers discovered that AI-QCA yielded accurate and consistent measurements of coronary stenotic lesions, comparable to IVUS, indicating its potential for safe use in clinical practice. This study represents a significant advancement in the application of AI in enhancing cardiovascular care. Although the study's results are promising, additional research is needed to fully understand the clinical utility and safety of AI-QCA.

“We believe that this novel tool could provide confidence to treating physicians and help in making optimal clinical decisions,” said Dr. In Tae Moon, the lead author of the study.

Related Links:
Uijeongbu Eulji University Hospital 
Medipixel

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Automated Cough Assist Device
Bionic Cough Simulator
New
Patient Warming Blanket
Patient Warming Blanket
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.